Empatica, founded in 2011, operates at the intersection of AI, Biotechnology, Hardware, Health Care, and Machine Learning. Based in the United States, the company develops advanced medical wearables designed to provide real-time human insights to patients, clinicians, and researchers.
Empatica’s cutting-edge technology includes a comprehensive ecosystem featuring a wristband, smartphone and desktop software, and real-time cloud synchronization. This platform focuses on affective computing and human data analytics, delivering medical-quality sensing for impactful healthcare applications.
The company’s recent financial milestone was a $25.95M Series B investment in August 2022, led by prominent investors such as RA Capital Management, Black Opal Ventures, and Sanofi Ventures. Empatica’s strategic positioning and innovative solutions make it an attractive prospect for investors passionate about advancing healthcare through technology.